Pharmaceutical Patent Due Diligence in M&A: The Definitive Analyst’s Guide to IP Valuation, Risk Quantification, and Deal Architecture
Part I: The Strategic Logic of Patent Due Diligence Why Pharma IP Is the Business, Not Just an Asset In […]
May 2025
Patent Box Tax Strategy for Pharma: The Complete IP & Investment Playbook
Every blockbuster drug carries two distinct asset classes: the molecule itself and the legal monopoly wrapped around it. The Patent
Patent Box Tax Strategy for Pharma: The Complete IP & Investment Playbook Read Post »
A Comprehensive Guide to Predicting Drug Market Potential
Introduction: Beyond the Crystal Ball – Forging Competitive Advantage in Pharma In the high-stakes world of pharmaceutical innovation, the chasm
A Comprehensive Guide to Predicting Drug Market Potential Read Post »
Exploring the Role of South Africa in the Global Pharmaceutical Landscape
Strategic Analysis of the South African Pharmaceutical Landscape The South African pharmaceutical market is the primary industrial and regulatory anchor
Exploring the Role of South Africa in the Global Pharmaceutical Landscape Read Post »
The Unbundling of the Apothecary: How Vertically Integrated Telehealth Is Dismantling the Pharmaceutical Value Chain
1. The Structural Dissolution of the Traditional Supply Chain The pharmaceutical industry has long relied on a fortress of opacity.
Drug Patents as Revenue Forecasts: The Pharma Analyst’s Complete Guide to IP-Based Sales Modeling and IP Valuation
Introduction: The Patent Filing Is a Financial Document The global prescription drug market cleared $1.6 trillion in annual revenue by
